LH

Laboratory Corporation o... (LH)

Laboratory Corporation of America Holdings

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NYSE:LH

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/05/08	21 : 08	Edgar (US Regulatory)	Form 8-K - Current report	NYSE:LH	Laboratory Corporation of America Holdings
2024/05/08	19 : 59	PR Newswire (US)	Labcorp to Webcast Its Annual Meeting of Shareholders	NYSE:LH	Laboratory Corporation of America Holdings
2024/05/08	05 : 05	PR Newswire (US)	Invitae Receives Court Approval for Sale to Labcorp	NYSE:LH	Laboratory Corporation of America Holdings
2024/05/07	05 : 40	Edgar (US Regulatory)	Form PX14A6G - Notice of exempt solicitation submitted by non-management	NYSE:LH	Laboratory Corporation of America Holdings
2024/04/29	20 : 00	PR Newswire (US)	Labcorp Receives FDA Approval for First Companion Diagnostic for Use with Pfizer's Newly Approved Gene Therapy to Treat Patients with Hemophilia B	NYSE:LH	Laboratory Corporation of America Holdings
2024/04/25	19 : 58	PR Newswire (US)	Labcorp Announces 2024 First Quarter Results	NYSE:LH	Laboratory Corporation of America Holdings
2024/04/25	10 : 27	PR Newswire (US)	Labcorp Announces Winning Bid for Select Assets of Invitae	NYSE:LH	Laboratory Corporation of America Holdings
2024/04/25	10 : 19	PR Newswire (US)	Invitae Enters into Agreement with Labcorp for Sale of Business	NYSE:LH	Laboratory Corporation of America Holdings
2024/04/15	20 : 00	PR Newswire (US)	Labcorp Announces First-of-Its-Kind Test for Early Indication of Neurodegenerative Diseases and Brain Injuries Using a Blood Draw	NYSE:LH	Laboratory Corporation of America Holdings
2024/04/11	19 : 59	PR Newswire (US)	Labcorp Declares Quarterly Dividend	NYSE:LH	Laboratory Corporation of America Holdings
2024/04/10	19 : 49	PR Newswire (US)	Labcorp Receives FDA Emergency Use Authorization for Mpox PCR Test Home Collection Kit	NYSE:LH	Laboratory Corporation of America Holdings
2024/04/08	20 : 00	PR Newswire (US)	Labcorp Announces Expansion of Precision Oncology Portfolio to Support Pharmaceutical, Biopharma, and Clinical Research in Advancing Drug Development Programs	NYSE:LH	Laboratory Corporation of America Holdings
2024/04/05	20 : 00	PR Newswire (US)	Labcorp Launches Labcorp® Plasma Detect™ Extending Leadership into Molecular Residual Disease (MRD) Clinical Research	NYSE:LH	Laboratory Corporation of America Holdings
2024/04/02	20 : 00	PR Newswire (US)	Labcorp to Present Diverse Portfolio of Precision Oncology Research at the Annual Meeting of the American Association for Cancer Research	NYSE:LH	Laboratory Corporation of America Holdings
2024/04/01	21 : 00	Business Wire	Xcell Biosciences Strengthens Cell and Gene Therapy Collaboration With Labcorp	NYSE:LH	Laboratory Corporation of America Holdings
2024/03/29	22 : 00	PR Newswire (US)	The Prelude Network® Names Labcorp Its Preferred Genetic Carrier Screening Lab	NYSE:LH	Laboratory Corporation of America Holdings
2024/03/28	21 : 00	PR Newswire (US)	Labcorp Announces Acquisition of Select Assets of BioReference Health's Diagnostics Business	NYSE:LH	Laboratory Corporation of America Holdings
2024/03/27	20 : 00	PR Newswire (US)	Labcorp to Announce First Quarter Financial Results on April 25, 2024	NYSE:LH	Laboratory Corporation of America Holdings
2024/03/20	20 : 00	PR Newswire (US)	Labcorp Launches pTau217 Blood Biomarker Test to Accelerate Path to Diagnosis of Alzheimer's Disease and Support Clinical Trials	NYSE:LH	Laboratory Corporation of America Holdings
2024/03/16	23 : 29	PR Newswire (US)	Labcorp Presents New Research Demonstrating Clinical Impact of Precision Diagnostics in Guiding Biomarker-targeted Therapies for Patients with Epithelial Ovarian Cancer	NYSE:LH	Laboratory Corporation of America Holdings
2024/03/11	21 : 59	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:LH	Laboratory Corporation of America Holdings
2024/03/11	21 : 56	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:LH	Laboratory Corporation of America Holdings
2024/03/08	03 : 16	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NYSE:LH	Laboratory Corporation of America Holdings
2024/03/08	00 : 34	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NYSE:LH	Laboratory Corporation of America Holdings
2024/03/07	21 : 00	PR Newswire (US)	Labcorp Launches Weight Loss Management Testing Solutions	NYSE:LH	Laboratory Corporation of America Holdings
2024/02/23	05 : 05	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:LH	Laboratory Corporation of America Holdings
2024/02/23	05 : 04	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:LH	Laboratory Corporation of America Holdings
2024/02/22	06 : 35	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NYSE:LH	Laboratory Corporation of America Holdings
2024/02/22	04 : 38	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NYSE:LH	Laboratory Corporation of America Holdings
2024/02/21	22 : 19	GlobeNewswire Inc.	Diagnostics Industry Leader Gary Huff Appointed to Biomerica Strategic Advisory Board	NYSE:LH	Laboratory Corporation of America Holdings